IL6 and type 2 diabetes mellitus: In addition, the production of pro-inflammatory cytokines including tumor necrosis factor (TNF)-α, IL-1β and IL-6 in the peripheral blood of T2DM patients was found to be decreased obviously after the administration of exendin-4 (He et al. 2013).